YU62900A - Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik - Google Patents

Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik

Info

Publication number
YU62900A
YU62900A YU62900A YUP62900A YU62900A YU 62900 A YU62900 A YU 62900A YU 62900 A YU62900 A YU 62900A YU P62900 A YUP62900 A YU P62900A YU 62900 A YU62900 A YU 62900A
Authority
YU
Yugoslavia
Prior art keywords
inhibitor
exchanger type
preparing sodium
hydrogen exchanger
nhe
Prior art date
Application number
YU62900A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Norma Jacqueline Tom
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU62900A publication Critical patent/YU62900A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/10Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YU62900A 1999-10-29 2000-10-16 Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik YU62900A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16237799P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
YU62900A true YU62900A (sh) 2003-08-29

Family

ID=22585372

Family Applications (1)

Application Number Title Priority Date Filing Date
YU62900A YU62900A (sh) 1999-10-29 2000-10-16 Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik

Country Status (19)

Country Link
US (1) US6441176B1 (https=)
EP (1) EP1101763A3 (https=)
JP (1) JP3342475B2 (https=)
KR (2) KR100449595B1 (https=)
CN (1) CN1146557C (https=)
AR (1) AR029188A1 (https=)
AU (1) AU779106B2 (https=)
BR (1) BR0005122A (https=)
CA (1) CA2324640A1 (https=)
CZ (1) CZ20004018A3 (https=)
HU (1) HUP0004187A2 (https=)
ID (1) ID27904A (https=)
IL (1) IL139198A0 (https=)
PL (1) PL343542A1 (https=)
RU (1) RU2190605C2 (https=)
TR (1) TR200003143A2 (https=)
TW (1) TWI221152B (https=)
YU (1) YU62900A (https=)
ZA (1) ZA200006007B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852733B2 (en) 2000-04-28 2005-02-08 Pfizer Inc. Sodium-hydrogen exchanger type 1 inhibitor
CA2436539A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
BR0215002A (pt) * 2001-12-19 2004-11-09 Pfizer Prod Inc Métodos de preparação de inibidores de permutadores de sódio-hidrogênio de tipo 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028381A (en) * 1975-05-05 1977-06-07 Ciba-Geigy Corporation Pyrazolobenzazepines
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
RU2009129C1 (ru) * 1991-12-16 1994-03-15 Центр по химии лекарственных средств Арилгидразоны 5,6,7,8-тетрагидрохинолиндионы-2,5, обладающие кардиотонической активностью
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
JP2002504546A (ja) 1998-02-27 2002-02-12 ファイザー・プロダクツ・インク 虚血の治療のためのn−[(置換5員ジもしくはトリアザ二不飽和環)カルボニル]グアニジン誘導体
UA72002C2 (en) 1999-10-29 2005-01-17 Pfizer Prod Inc Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage

Also Published As

Publication number Publication date
JP2001158784A (ja) 2001-06-12
PL343542A1 (en) 2001-05-07
JP3342475B2 (ja) 2002-11-11
HK1036057A1 (en) 2003-07-10
ID27904A (id) 2001-05-03
CN1146557C (zh) 2004-04-21
HUP0004187A2 (hu) 2002-11-28
KR20010060211A (ko) 2001-07-06
EP1101763A2 (en) 2001-05-23
CN1295070A (zh) 2001-05-16
HU0004187D0 (https=) 2001-01-29
BR0005122A (pt) 2001-06-19
AU779106B2 (en) 2005-01-06
TWI221152B (en) 2004-09-21
CZ20004018A3 (cs) 2002-04-17
US6441176B1 (en) 2002-08-27
KR100449595B1 (ko) 2004-09-21
AU6133300A (en) 2001-05-03
KR100443851B1 (ko) 2004-08-11
AR029188A1 (es) 2003-06-18
IL139198A0 (en) 2001-11-25
ZA200006007B (en) 2002-04-26
RU2190605C2 (ru) 2002-10-10
TR200003143A2 (tr) 2001-05-21
KR20030061767A (ko) 2003-07-22
EP1101763A3 (en) 2002-04-24
CA2324640A1 (en) 2001-04-29

Similar Documents

Publication Publication Date Title
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
AP9901478A0 (en) Compounds for the treatment of ischemia.
CA2441313A1 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
MXPA02009706A (es) Metodo para sintesis de perindopril y sus sales farmaceuticamente aceptables.
GB9929552D0 (en) Compounds
PT883405E (pt) Inibidores de amidino-protease
WO2000005214A3 (en) Isoquinolines as urokinase inhibitors
BG104575A (en) Matrix metalloprotease inhibitors
AU2002210425A1 (en) Novel beta-amyloid inhibitors, method for producing the same and the use thereofas medicaments
ATE229800T1 (de) Guanidino proteiase inhibitoren
YU62900A (sh) Postupak za dobijanje inhibitora za tip 1 izmenjivača natrijum-vodonik
MXPA03004879A (es) Inhibidores de farnesiltransferasa.
FI20000553L (fi) Proteaasi-inhibiittoreina käyttökelpoisten 4-hydroksi-2-oksopyraanijohdannaisten valmistusmenetelmä
AP2002002651A0 (en) Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
BG105249A (en) Fkbp inhibitors
AP2002002493A0 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.
PL331330A1 (en) Method of obtaining derivatives of 3-pyroline-2-carboxylic acid
YU1500A (sh) Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijena jedinjenja i korišćenje ovih jedinjenja
PT1276722E (pt) Inibidores de naftamidina-uroquinase
BG103321A (en) Method for the preparation of phenoxyphenylsulphonyl halogenides
AU2002337460A1 (en) Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
AP2001002047A0 (en) Isoquinoliness as urokinase inhibitors.
IT1303685B1 (it) Procedimento per la preparazione di acidi alfa-arilalcanoici